The aim of this study was to investigate whether tumour-derived AR mutations in the plasma of patients with PCa are primarily present in EV DNA or cfDNA and to determine which target exhibits higher sensitivity in detecting AR mutations. The gene discussed is AR; the disease is neoplasm.